ATS 2019 Virtual Final Program

P740 The Modelling of Correlation Between Internal and External Factors on Self-Assessment of Environmental Impact on Health-Related Quality of Life in Patients with Asthma/ N. Perelman, N. Bezrukov, Blagoveshchensk, Russian Federation, p.A3027 P741 Non-Respiratory Symptoms Are as Important as Respiratory Symptoms in Their Impact on Quality of Life in Severe Asthma/ R. Jones, J. Lanario, Y. Wei, M. Hyland, M. Masoli, Plymouth, United Kingdom, p.A3028 Facilitator : S.E. Zaeh, MD, Baltimore, MD P742 The Asthma Control Test as a Community Education and Research Tool for Children and Families/ M.A. Martin, G. Mosnaim, A. Roy, G. Rosales, M. Hernandez Contreras, D. Guerrero, A. Fragoso, S. Walton, Chicago, IL, p.A3029 P743 Fractional Exhaled Nitric Oxide Measurement: Comparison Between Sunvou-CA2122 Analyzer and NIOX VERO Analyzer/ T. Huang, B. Liu, C. Liu, Chengdu, China, p.A3030 P744 Prevalence of Alexithymia Among Patients with Asthma from Latin-America and Association with Control, Severity of Disease and Adherence to Treatment/ I. Cherrez, O. López-Jové, J.C. Calderon, E. Vanegas, M. Felix, J. Espinoza-Plaza, E. Matos, C. Galván, D. Garcìa, E. Sánchez, G. Ramón, I. Tinoco, J.A. Cano, Samborondón, Ecuador, p.A3031 P745 Cultural Sensitivities and Asthma Health Beliefs/ M. Ramagopal, S. Rai, New Brunswick, NJ, p.A3032 P746 Can Add-on Treatment of Azithromycin Improve Clinical Outcomes in Asthma Patients? A Systematic Review and Meta-Analysis/ X. Wang, D. Wang, D. Yang, C. Liu, Chengdu, China, p.A3033 P747 Differences in the Preferences of Allergists and Pulmonologists for their Ideal Administration Route of Severe Asthma Biologic Therapies/ A. Kyle, K. Hanarz, S. Brown, London, United Kingdom, p.A3034 P748 Disease Status Affects Symptomatic Patients’ Preferences for Maintenance Inhaler Therapies: Discrete Choice Experiment/ N.A. Hanania, T. Tervonen, N. Hawken, I. Gilbert, S. Heidenreich, F.J. Martinez, Houston, TX, p.A3035 P749 Self-Monitoring of Lung Function in Mild Asthma Patients Using Connected Mobile Spirometry System - Feasibility Study/ L. Koltowski, A. Hofman, M. Kupczyk, P. Kuna, M. Lukaszyk, K. Buczylko, P. Dabrowiecki, A. Bodzenta-Lukaszyk, P. Nastalek, M. Solinski, Warsaw, Poland, p.A3036 P750 Feasibility and Accuracy of Tele-Spirometry: A Community Based Approach/ M. Kumar, A. Agarwal, P. Pant, S. Bhatt, M. Singh, M. Singh, Chandigarh, India, p.A3037 Facilitator : E. Oren, PhD, MS, San Diego, CA P751 Characterizing a Digital Health Footprint for Asthma/ C.L. Carroll, V. Kaul, K.A. Sala, N.S. Dangayach, Hartford, CT, p.A3038 P752 iPREDICT: Transforming Severe Uncontrolled Asthma Management and Patient Outcomes Using Digital Technology/ L. Hagger, B. Dutta, M. Jörnten-Karlsson, Gaithersburg, MD, p.A3039 P753 Influence of the Number Multiple Disease-Modifying Factors in Japanese Patients with Severe Asthma/ R. Watanabe, R. Baba, T. Kamatani, M. Kuwae, S. Okuzumi, T. Tanosaki, M. Matsusaka, T. Mochimaru, H. Kabata, S. Ueda, Y. Suzuki, K. Asano, K. Fukunaga, Tokyo, Japan, p.A3040 P754 Urinary Excretion Pharmacokinetics to Assess Lung and Systemic Exposure of Inhaled Albuterol When Using a pMDI Technique Training Tool/ W.G. Ammari, M. Sanders, Amman, Jordan, p.A3041 P755 The Relationship Between Social Capital and Asthma Control/ A. Saito, T. Hasegawa, T. Koya, S. Nagumo, Y. Nishiyama, K. Yoshizawa, H. Ueno, Y. Kimura, M. Hayashi, Y. Shobugawa, R. Saito, T. Kikuchi, Niigata, Japan, p.A3042 P756 Asthma Readmission at UTMB/ A. Ogedegbe, R. Sellappan, W.J. Calhoun, League City, TX, p.A3043 P757 Cost Implications of Fluticasone Furoate/Vilanterol (FF/VI) Versus Usual Care (UC): Results from the Salford Lung Study (SLS) in Asthma Applied in a US Context/ H. Svedsater, G. van de Wetering, T. Ignacio, M.T. Driessen, D. Browning, Brentford, United Kingdom, p.A3044 CLINICAL THEMATIC POSTER SESSION B38 LUNG CANCER: SCREENING PRACTICES AND TREATMENT OUTCOMES 9:15 a.m. - 4:15 p.m. KBHCCD Area A (Hall F, Level 2) Viewing: Posters will be on display for entire session. Discussion: 11:15-12:00: authors will be present for individual discussion 12:00-1:00: authors will be present for discussion with assigned facilitators. Facilitator : A.C. Melzer, MD, MS, Minneapolis, MN P32 Early Patterns in Lung Cancer Screening at an Academic Medical Center/ J. Willoughby, L. Dowling, P. Shah, B.T. Tran, Chicago, IL, p.A3045 P33 Survey of Lung Cancer Screening Practices of Internal Medicine House Staff/ R. Amirahmadi, A.J. Kumar, J. Deepak, Baltimore, MD, p.A3046 P34 The Waiting Game: Timeliness in Lung Cancer Screening in an Urban Population/ C. Brillante, K. Haas, M.J. Joo, Chicago, IL, p.A3047 P35 Understanding and Improving the Lung Cancer Screening Process Across Healthcare Systems: A Conceptual Screening Model for the Lung Population-Based Research to Optimize the Screening Process (PROSPR) Research Center/ K. Rendle, A.N. Burnett-Hartman, C. Nesland-Dudas, R.T. Greenlee, S. Honda, J. Elston Lafata, P.M. Marcus, M.E. Cooley, R. Meza, C. Oshiro, M.D. Schnall, A. Vachani, V.P. Doria-Rose, C. Doubeni, D.P. Ritzwoller, Philadelphia, PA, p.A3048 ATS 2019 • Dallas, TX MONDAY • MAY 20 151 MONDAY MORNING